Cutaneous toxicity with subepidermal blisters and dyskeratosis following administration of pemetrexed in a patient with nivolumab-induced psoriasis and linear IgA bullous dermatosis

J Dermatol. 2024 Feb;51(2):e57-e58. doi: 10.1111/1346-8138.16974. Epub 2023 Sep 21.

Authors

Sayuri Yokomizo¹, Tomoko Miyake¹, Yoshio Kawakami¹, Kadoaki Ohashi², Hiroshi Koga³, Norito Ishii³, Shin Morizane¹

Affiliations

¹ Department of Dermatology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan.
² Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan.
³ Department of Dermatology, Kurume University School of Medicine, Fukuoka, Japan.

PMID: 37735962
DOI: 10.1111/1346-8138.16974

No abstract available

Publication types

Letter

MeSH terms

Blister / chemically induced
Humans
Immunoglobulin A
Linear IgA Bullous Dermatosis* / chemically induced
Linear IgA Bullous Dermatosis* / diagnosis
Nivolumab / adverse effects
Pemetrexed / adverse effects
Psoriasis* / drug therapy
Skin Abnormalities*
Skin Diseases*

Substances

Pemetrexed
Nivolumab
Immunoglobulin A